JavaScript is disabled for your browser. Some features of this site may not work without it.

There are no files associated with this item.

Title:

Revival of the regulatory T cell: new targets for drug development.

Author(s):

Sutmuller, R.P.M.; Offringa, R.; Melief, C.J.

Publication year:

2004

Source:

Drug Discovery Today, vol. 9, iss. 7, (2004), pp. 310-316

ISSN:

1359-6446

Publication type:

Article / Letter to editor

Please use this identifier to cite or link to this item :http://hdl.handle.net/2066/58940

Display more details

Subject:

UMCN 1.4: Immunotherapy, gene therapy and transplantation

Organization:

TumorimmunologyUMCN Extern

Journal title:

Drug Discovery Today

Volume:

vol. 9

Issue:

iss. 7

Page start:

p. 310

Page end:

p. 316

Abstract:

Compelling new evidence supports the idea that regulatory T cells play a major role in our immune system. Several subsets of these regulators have been identified recently. Differences in the phenotypical and functional characteristics of these subsets have immunological implications. From our growing knowledge of the field of immunology, we could potentially generate a new class of therapeutic agents that target immune-related diseases.